AzTrials
AzTrials

Smoking BehaviorsTREATINTSMOKENCT06900985

Therapeutic Contact Intensity in a Psychological Smoking Cessation Intervention With an App

A study testing 8-sessions CBT + App, 4-sessions CBT+App and Smoking cessation App in people with Smoking Behaviors, run by University of Santiago de Compostela at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

This randomized controlled trial intends to examine the efficacy of a smoking cessation intervention with an App according to the intensity of therapeutic contact. Participants will be assigned to one of three groups. The first group will receive eight sessions with trained psychologists alongside access to the App. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Smoking Behaviors
What is being tested?
8-sessions CBT + App, 4-sessions CBT+App and Smoking cessation App
Could I receive a placebo?
No, everyone receives an active treatment
How many people
429 participants
Where
1 siteSpain
Study dates
1 Sep 2026to Apr 2028
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • aged 18 or over
  • wishing to participate in the treatment
  • providing written informed consent
  • smoking at least 5 cigarettes per day
  • completion of all pre-treatment assessment questionnaires
  • having a valid email address
  • having an Android or iOS smartphone and being willing to use it throughout the treatment

Who cannot join

  • a diagnosis of severe mental disorder (bipolar disorder and/or psychotic disorder)
  • concurrent substance use disorder (alcohol, cannabis, stimulant, hallucinogen and/or opioid)
  • using other tobacco products (electronic cigarette with nicotine, cigars or cigarillos)
  • having completed an effective psychological treatment to quit smoking during the previous year
  • having completed a pharmacological treatment to quit smoking in the last year (any smoking cessation medication approved by the Agencia Española del Medicamento)
  • having a physical pathology involving high vital risk that requires immediate intervention (e.g., recent myocardial infarction)
  • having visual difficulties that prevent the use of the App.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ana López-Durán, Phd. contact

+34 881813774

ana.lopez@usc.es

Spain1 site, 1 recruiting
  • Smoking Cessation and Addictive Disorders Unit

    Santiago de Compostela, A Coruña, 15885

    Ana Lopez Duran, Phd, +34 881813939, unidad.tabaquismo@usc.gal

    Recruiting

Other trials in Spain

About this study

Official title: Assessment of a Psychological Treatment for Smoking Cessation Combined With an App According to the Intensity of Therapeutic Contact: Randomized Controlled Trial

This randomized controlled trial intends to examine the efficacy of a smoking cessation intervention with an App according to the intensity of therapeutic contact. Participants will be assigned to one of three groups. The first group will receive eight sessions with trained psychologists alongside access to the App. The second group will receive four sessions with trained psychologists plus App access. The control group will only have access to the App. This study seeks to determine the impact of different levels of therapeutic contact on abstinence outcomes.

Read the detailed description

Smoking remains the leading preventable cause of morbidity and mortality worldwide. It is crucial to implement preventive measures to reduce the likelihood of people starting to smoke but also to make effective smoking cessation treatments available to those who smoke. Psychological interventions have proven to be effective to quit smoking and are considered first-choice interventions, especially for specific populations such as adolescents or pregnant women . The motivation behind this proposal is to improve the effectiveness of smoking cessation treatments based on our clinical and research experience in smoking cessation psychological interventions. Although we have very effective psychological treatments, producing abstinence rates of approximately 70% at the end of the treatment, and 35% at one year of follow-up to continue improving its effectiveness and reduce relapse rates is warranted. Furthermore, technological advances can help increase accessibility to available treatments and motivation to participate in smoking cessation interventions.

The main objective of this proposal is to assess the efficacy of a cognitive-behavioral treatment for smoking cessation with new components (anhedonia and mood management, physical activity, and positive social support) according to the intensity of the therapeutic contact, through a randomized controlled trial. The treatment will be conducted through video call format to make it more accessible. The study will compare three groups that will receive treatments of varying intensity of therapeutic contact: 1) 8 intervention sessions + App (Experimental Group 1, EG1), 2) 4 intervention sessions + App (Experimental Group 2, G2), and 3) no therapeutic contact, App only (control group/CG). Our initial hypothesis is that the higher intensity intervention (EG1) will be more effective than EG2 and CG groups in abstinence outcomes at the end of the intervention and in reducing relapse rates for one year follow-up. The EG2 will be more effective than the CG in abstinence outcomes at the end of the intervention and in reducing relapse rates during one-year follow-up.

Digital treatment delivery formats will be used to increase treatment accessibility: 1) treatment sessions will be conducted through video calls which will remove geographical and time-related barriers. This format will be particularly useful for smokers experiencing barriers to access to treatment due to work/family schedules; 2) a smoking cessation App will be used to improve adherence and access to treatment components anytime, anywhere. Moreover, integrating technology into the treatment can facilitate participants intersessions tasks and support the work of professionals. Our previous experience with an App as a complement to the smoking cessation intervention showed excellent abstinence outcomes.

Being tested
8-sessions CBT + App, 4-sessions CBT+App, Smoking cessation App
Keywords
smoking, treatment, cognitive-behavioral, therapeutic-contact intensity, digital intervention, eHealth, randomized controlled trial
Medical subject headings
Smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 8-sessions CBT + AppBehavioural

    It will consist of 8 one-hour sessions applied in group format once a week and participants will be followed at 3, 6, and 12 months. The sessions will be conducted by clinical psychology/general health psychology professionals and will be carried out using video calls. The smoking cessation treatment follows a cognitive-behavioral approach with components for anhedonia reduction, increased physical activity and positive social support, being a modified, multidisciplinary, and extended version of the original smoking cessation program (Becoña, 2007; Becoña et al., 2017). The treatment will be complemented with an App with active therapeutic components that participants will use during treatment and the one-year follow-up period.

  • 4-sessions CBT+AppBehavioural

    It will consist of 4 one-hour sessions applied in group format every two-weeks (8 weeks total duration) and participants will be followed at 3, 6, and 12 months. The sessions will be conducted by clinical psychology/general health psychology professionals and will be carried out using video calls. The 4 sessions will have the following content: 1) explanation of treatment rationale and components available in the App; 2) participants' progress monitoring, reinforcement of achieved goals, and analysis of difficulties; 3) cessation planning support; and 4) relapse prevention support. The treatment sessions will be protocolized in a treatment manual. The treatment will be complemented with the same App that the other conditions

  • Smoking cessation AppBehavioural

    It will consist in the same App than the other two conditions. No therapeutic contact will be avaliable.

Study groups in NCT06900985
Study groupRoleWhat they receive
1. High-intensity therapeutic contact cognitive-behavioral treatment for smoking cessation with AppActive comparatorIt will consist of an App and 8 one-hour sessions applied in group format once a week (8 weeks total duration). The sessions will be conducted by trained clinical psychology/general health psychology professionals and will be carried out using video calls.
Receives: Behavioral: 8-sessions CBT + App
2. Medium-intensity therapeutic contact CBT for smoking cessation with AppActive comparatorIt will consist of an App and 4 one-hour sessions applied in group format every two-weeks (8 weeks total duration). The sessions will be conducted by trained clinical psychology/general health psychology professionals and will be carried out using video calls.
Receives: Behavioral: 4-sessions CBT+App
3. App only (no therapeutic-contact group).Active comparatorIt will consist of the same App than participants assigned to Conditions 1 and 2, but without contact with professionals
Receives: Behavioral: Smoking cessation App

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 7-days point prevalence abstinence

    The abstinent status will be defined as not having smoked in the last 7 days (not even a puff)

    Measured: At 12-months post-intervention

Secondary outcomes (3)
  1. 7-days point prevalence

    The abstinent status will be defined as not having smoked in the last 7 days (not even a puff)

    Measured: At 3 and 6-months post-intervention

  2. 7-days point prevalence abstinence

    The abstinent status will be defined as not having smoked in the last 7 days (not even a puff)

    Measured: At 7-days post-quit day

  3. Satisfaction with the intervention

    Scores obtained in Client Satisfaction Questionnaire (CSQ-8; Larsen et al., 19979; Spanish version of Vázquez et al., 2017)

    Measured: At 8-weeks after beginning the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2025
  2. Study start1 Sep 2026
  3. Primary completionApr 2028 (estimated)
  4. Study completionApr 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
429 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06900985
Sponsor's protocol ID
PID2023-146663OB-I00
Acronym
TREATINTSMOKE
Status last verified
Oct 2026
First submitted
21 Mar 2025
Last updated
23 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Lopez-Duran A, Martinez-Vispo C, Martinez U, Rodriguez-Cano R, Cortes-Garcia L, Miguez MC, Barroso-Hurtado M, Ramos-Carro M, Moss-Alonso E, Vacas J, Millara L, Tubio A, Becona E. Therapeutic contact intensity as an adjunct to a cognitive behavioral smoking cessation app: protocol for a randomized controlled trial. Addict Sci Clin Pract. 2026 Jun 11. doi: 10.1186/s13722-026-00684-0. Online ahead of print.

    PubMed 42271518

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in